Drug recall
Apheresis Platelets, Leukocytes Reduced, Irradiated
FDA recall event 84554 · Class III · Stanford Blood Center
Key facts
| Event ID | 84554 |
|---|---|
| Recall numbers | B-0239-2020 |
| Recalling firm | Stanford Blood Center |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced, Irradiated |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis product, identified as unsuitable due to a collection deviation, was distributed. |
| Initiation date | Nov 7, 2019 |
| Report date | Feb 5, 2020 |
| Termination date | Jan 28, 2020 |
| City | Palo Alto |
| State | CA |
| Country | United States |
| FEI number | 2970004 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: